Cargando...
Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis
BACKGROUND: We performed a meta-analysis of cholinesterase inhibitors for patients with Lewy body disorders, such as Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies. METHODS: The meta-analysis included only randomized controlled trials of cholinesterase inhibitors fo...
Guardado en:
| Publicado en: | Int J Neuropsychopharmacol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772820/ https://ncbi.nlm.nih.gov/pubmed/26221005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyv086 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|